Real-world utilisation of upfront chemohormonal therapy in metastatic hormone-sensitive prostate cancer

被引：0

作者：

Kelly, R. ^{[1
]}

Wong, S. S. L. ^{[2
]}

Shapiro, J. ^{[3
]}

Weickhardt, A. J. ^{[4
]}

Parente, P. ^{[5
]}

Azad, A. ^{[6
]}

Uccellini, A. ^{[7
]}

Torres, J. ^{[8
]}

Parnis, F. ^{[9
]}

Kwan, E. ^{[10
]}

Brown, S. ^{[11
]}

Steer, C. ^{[12
]}

Warren, M. ^{[13
]}

Gibbs, P. ^{[14
]}

Anton, A. ^{[1
]}

Tran, B. ^{[1
]}

机构：

[1] Walter Eliza Hall Inst Med Res, Clin Data Clin Trials & Biomarkers, Parkville, Vic, Australia

[2] Sunshine Hosp Western Hlth, Med Affairs Dept, St Albans, Vic, Australia

[3] Alfred Hosp, Med Oncol, Melbourne, Vic, Australia

[4] Olivia Newton John Canc Wellness & Res Ctr, Dept Med Oncol, Heidelberg, Vic, Australia

[5] Box Hill Hosp, Eastern Hlth, Dept Med Oncol, Bldg B, Box Hill, Vic, Australia

[6] Peter MacCallum Canc Ctr, Dept Oncol, Melbourne, Vic, Australia

[7] Austin Hosp, Austin Hlth, Med Oncol, Heidelberg, Vic, Australia

[8] Goulburn Valley Hlth, Dept Med Oncol, Shepparton, Vic, Australia

[9] Adelaide Canc Ctr, Dept Med Oncol, Adelaide, SA, Australia

[10] Monash Canc Ctr, Monash Hlth, Med Oncol, Bentleigh East, Vic, Australia

[11] Ballarat Hlth Serv, Med Oncol, Ballarat Base Hosp, Ballarat, Vic, Australia

[12] Border Med Oncol, Dept Med Oncol, East Albury, Vic, Australia

[13] Bendigo Hlth, Med Oncol, Bendigo, Vic, Australia

[14] WEHI Walter & Eliza Hall Inst Med Res, Dept Oncol, Parkville, Vic, Australia

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷

关键词：

D O I：

10.1016/j.annonc.2022.10.202

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

165P

引用

页码：S1498 / S1499

页数：2

共 50 条

[1] Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Sweeney, Christopher J.
Chen, Yu-Hui
Carducci, Michael
Liu, Glenn
Jarrard, David F.
Eisenberger, Mario
Wong, Yu-Ning
Hahn, Noah
Kohli, Manish
Cooney, Matthew M.
Dreicer, Robert
Vogelzang, Nicholas J.
Picus, Joel
Shevrin, Daniel
Hussain, Maha
Garcia, Jorge A.
DiPaola, Robert S.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (08): : 737 - 746
[2] Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Mathieu, Romain
Shariat, Shahrokh F.
[J]. EUROPEAN UROLOGY, 2016, 69 (04) : 755 - 756
[3] Re: Chemohormonal Therapy in Metastatic Hormone-sensitive Prostate Cancer
de Reijke, Theo
[J]. EUROPEAN UROLOGY, 2016, 69 (01) : 178 - 178
[4] Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Murphy, Declan G.
Zargar, Homayoun
[J]. EUROPEAN UROLOGY, 2016, 69 (03) : 540 - 540
[5] Predictors of real-world utilisation of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer
Azad, Arun A.
Tran, Ben
Davis, Ian D.
Parente, Phillip
Evans, Melanie
Wong, Shirley
Brown, Stephen
Evans, Sue
Millar, Jeremy
Murphy, Declan G.
Papa, Nathan
[J]. INTERNAL MEDICINE JOURNAL, 2022, 52 (08) : 1339 - 1346
[6] Chemohormonal Therapy in Hormone-Sensitive Prostate Cancer
Ciccarese, Chiara
Santoni, Matteo
Massari, Francesco
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (03): : 286 - 286
[7] Chemohormonal therapy for metastatic hormone-sensitive prostate cancer: An Asian perspective
Teoh, Jeremy Yuen-Chun
Ng, Chi-Fai
Poon, Darren Ming-Chun
[J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 5 - 8
[8] Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer
Sathianathen, Niranjan J.
Philippou, Yiannis A.
Kuntz, Gretchen M.
Konety, Badrinath R.
Gupta, Shilpa
Lamb, Alastair D.
Dahm, Philipp
[J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (10):
[9] Chemohormonal Therapy for Hormone-Sensitive Prostate Cancer: A Review
Kyriakopoulos, Christos E.
Liu, Glenn
[J]. CANCER JOURNAL, 2016, 22 (05): : 322 - 325
[10] Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer Editorial Comment
Taneja, Samir S.
[J]. JOURNAL OF UROLOGY, 2016, 195 (01): : 94 - 94

← 1 2 3 4 5 →